A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors
/in Dendritic Cells, Gallbladder Cancer, International Publications, Pancreatic Cancer /von 2008-01-01 / Cancer Ther 2008;6(B):955-964Immunotherapeutic approaches in pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2008-01-01 / Recent Results Cancer Res. 2008;177:165-77Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma
/in International Publications, Pancreatic Cancer /von 2007-07-24 / J. Natl. Cancer Inst. 2007 Aug;99(15):1188-99Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model
/in International Publications, Pancreatic Cancer /von 2007-03-29 / Gut 2007 Sep;56(9):1275-82[Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma]
/in International Publications, Pancreatic Cancer /von 2006-09-01 / Ai Zheng 2006 Sep;25(9):1082-6Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
/in International Publications, Pancreatic Cancer /von 2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-83[Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]
/in International Publications, Pancreatic Cancer /von 2006-04-11 / Zhonghua Yi Xue Za Zhi 2006 Apr;86(14):943-6Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3709-14Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
/in International Publications, Pancreatic Cancer /von 2005-07-01 / J. Immunother. 2005 Jul-Aug;28(4):332-42IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de